BURNETT JOSEPH 4

What Happened
Joseph M. Burnett, CEO, President and a director of ClearPoint Neuro, sold 19,951 shares of CLPT on February 25, 2026 in an open-market transaction for a total of approximately $302,657 (weighted average price $15.17). The sale was reported on a Form 4 filed February 26, 2026.

Key Details

• Transaction type: Sale (S) — open market / private sale reported as S.
• Date of transaction: 2026-02-25; Form 4 filed: 2026-02-26 (appears timely).
• Shares sold: 19,951 at a weighted average price of $15.17 (price range $15.15–$15.25).
• Proceeds: ~$302,657.
• Footnote highlights:
  • The sale was made under a Rule 10b5-1 written trading plan adopted June 11, 2025 (F1).
  • Weighted average and price range disclosed; reporter can provide breakdown of shares sold at each price (F2).
  • Notes about a trust: 934 shares were transferred from the Joseph M. Burnett Trust to Mr. Burnett on Feb 6, 2026 (F3); some shares remain owned by the Trust and indirectly by Mr. Burnett as trustee (F4).
• Shares owned after the transaction: not specified in the provided filing details.

Context
This was a sale under a pre-established 10b5-1 plan, which is commonly used to execute planned trades and reduce the appearance of trading on material nonpublic information. Sales do not necessarily indicate a change in confidence about the company; they can be routine liquidity or portfolio-management transactions.